Biohacking Market Research Report - forecast till 2023

Biohacking Market Research Report - forecast till 2023

ID: MRFR/HC/3719-CRR | September, 2018 | Region: Global | 157 pages | Cooked Research Reports

Global Biohacking Market: Information by Type (Inside, Outside), Product (Smart Drugs, Sensors, Strains, Others), Application (Synthetic, Genetic Engineering, Others), End-user (Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others), Region—Forecast till 2023


Market Synopsis


Biohacking refers to the use of function-enhancing drugs or the use of external or internal implants to improve cognitive function, memory, and creativity in individuals. The most prolific method include the intake of nootropic drugs to develop intelligence and focus. It is also known as do-it-yourself (DIY) biology. Biohackers have set up shop in warehouses, garages, and other such spaces. Some of the well-known labs in the U.S. include Biogarage, Bioartlab, Genspace, BioCurious, and LA Biohackers.


Awareness of biohacking, prevalence of chronic diseases, and demand for smart devices and durgs are factors likely to drive the market growth over the forecast period (2017-2023). The biohacking market can mushroom in size at a 19.42% CAGR during the assessment period owing to continuous technological advances. Lack of cyber security practices can deter the market growth. The sharp rise noticed in chronic diseases coupled with the growing geriatric populace is expected to provide opportunities for the market to grow.


The increasing use of radiofrequency identification (RFID) technology in medical devices combined with the penetration of internet of things (IoT) in healthcare, fitness, and consumer electronics is expected to push the market demand. This can be credited to the need for quality healthcare needs among the populace.


Report Overview


The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts make highly astute projections regarding the scope of the market and its future prospects. MRFR’s report includes a thorough analysis of the global biohacking market segmented by type, product, application, end-user, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.


Segment Overview


By type, the global biohacking market is segmented into outside and inside biohacking. Product-wise, the market is segmented into strains, sensors, smart drugs, and others. Major applications include synthetic biology, forensic science, genetic engineering, diagnosis & treatment, drug testing, and others. End-users in the market include pharmaceutical & biotechnology companies, forensic laboratories, and others.


The segments covered in the biohacking market report are analyzed with respect to four major regions – Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA), with respective country-level market sizing. The report discusses in detail the various players residing in these regions and their respective strategies to climb up the market ladder.


Competitive Landscape


Noteworthy industry participants in the biohacking market include Thync Global Inc. (U.S.), Synbiota (Canada), Apple (U.S.), HVMN, Inc. (U.S.), MoodMetric (U.S.), THE ODIN (U.S.), and Fitbit, Inc. (U.S.). The report offers comprehensive profiles on these market players and assesses their current standing in the market. Company history coupled with annual turnover, profit margins, segmental share, SWOT analysis, growth strategies, expansion techniques, and latest R&D initiatives are discussed in minute detail.


Research Methodology


At MRFR, our research analysts conduct a thorough objective analysis of the market when creating market reports by adhering to a rigorous set of standards which allow a truly comprehensive view of the market. Use of primary research strategies such as interviews with top executives of biohacking kits and tools manufacturers. Secondary research entails a thorough analysis of past and present trends in a forward-looking manner. Additionally, market size estimation and validation use both top-down & bottom-up approaches to obtain data from the value and supply chain. The balanced number of buyers and suppliers will result in a negligible demand-supply gap. Credible resources are accessed and verified by analysts to understand the nuances of market factors with consistency. Competent data analysts use strong analytical tools to ascertain accurate analysis of very relevant parameters in an effort to provide clients with a conclusive and dependable view of the future.


Analysis Period



  • Base Year - 2016

  • Projection Period - From 2017 to 2023

  • Market Denomination - USD Million

  • Conversion Rate - Considered as per the respective financial years


For the scope of research, the report offers a comprehensive analysis of the global biohacking market.


Product



  • Smart Drugs

  • Sensors

  • Strains

  • Others


Application



  • Synthetic Biology

  • Genetic Engineering

  • Forensic Science

  • Diagnosis & Treatment

  • Drug Testing


End-user



  • Pharmaceutical & Biotechnology Companies

  • Forensic Laboratories

  • Others


Region



  • Americas

    • The U.S.

    • Canada

    • South America





  • Europe

    • Germany

    • France

    • The U.K.

    • Italy

    • Spain

    • Rest of Western Europe

    • Eastern Europe





  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Republic of Korea

    • Rest of Asia Pacific





  • The Middle East & Africa

    • Qatar

    • Kuwait

    • Oman

    • Saudi Arabia

    • United Arab Emirates

    • Rest of Middle East & Africa




Intended Audience



  • Government Research Laboratories

  • Research and Development (R&D) Companies

  • Private Research Laboratories

  • Biopsy Devices Manufacturers

  • Market Research and Consulting Service Providers

  • Biopsy Devices Suppliers

Biohacking Market – Summary


The healthcare sector is moving gradually towards customization of treatment. The cure for a particular disease depends mostly on individual biology and more the knowledge, more the chances for finding a better cure for various diseases. Many can consider biohacking or Do-it-Yourself (DIY) biology as avant-garde, but it’s the next leap that synthetic biology is making. The procedure includes constant monitoring of an individual’s biology with a blend of medical, nutritional, and electronic technique. The lab experiments are done in this process on a much smaller and focused scale to explore various possibilities associated with biotechnology, molecular biology, genetic engineering, and many other aspects. Among the different experimental techniques, inserting a microchip into the body to control the stress level or monitor heart rate has gained momentum.


Prevalence of chronic diseases, such as diabetes and cancer, is one major driving force that is triggering the market growth. As per the reports of the American Cancer Association, 13% of the population are often diagnosed with cancer before they cross age 20. The American Diabetic Association indicates that 9.3% of the entire population is suffering from diabetes. Such chronic diseases are always a burden on the country as they reduce productivity considerably. Early diagnosis is the only way out and is a belief that is triggering the biohacker market growth.


Advancing technologies have also infused the healthcare market with innovative medical devices and sensors, and the sector is growing by leaps and bounds. But its just the beginning as a constant influx of upgradation is also expected to create healthcare-related awareness and would widen the horizon of the market. Various technologies such as radio frequency identification (RFID) and the inclusion of the internet of things (IoT) have gained momentum in the sector. Their application in various gadgets has charmed a particular section of the populace which in consequence is propelling the market ahead in an unprecedented way.


On the flip side, the market can witness a perforating effect from cybercrimes. Web hackers’ invasion can leak confidential data which can have a detrimental impact on the market. At the same time, insulin pumps, cochlear implants, and pacemakers can be accessed remotely which could result in fatal consequences or divulge personal information. This can bottleneck the market for a short span of time. However, gadget-friendly generation can give the market a new direction.


Segmentation Analysis:


Type-wise segmentation includes outside and inside biohacking. Outside biohacking had a market valuation of USD 4,579.35 million in 2017 which is expecting almost quadruple rise during the forecast period to USD 16,142.38 million with the fastest CAGR of 19.72%. Inside biohacking is also gaining considerable ground and is touted to inflate with an 18.88% CAGR during the same period.


By product, the market can be segmented into smart drugs, sensors, strains, and others. Smart drug segment is spearheading the market, and its growth from a valuation of USD 3,367.33 million to a predicted USD 11,980.71 million in 2023 is impressive as it gives a peek into the biohacker market’s proliferation. The sub-segment is also going to have the fastest CAGR of 19.88% during the review period.


Based on applications, the market can be segmented into synthetic biology, genetic engineering, forensic science, diagnosis & treatment, drug testing, and others. Synthetic Biology to grow substantially and dominate the market during the assessment period by having a valuation of USD 3,255.75 million. The segment will also ensure a significant foothold with the maximum CAGR of 19.81% during the same period.


Based on end-users, the market can be segmented into pharmaceutical & biotechnology companies, forensic laboratories, and others. Pharmaceutical & biotechnology companies held the most significant share of the globally generated revenue in 2017, and during the forecast period, it can rise to a valuation of USD 13,882.08 million. An impressive CAGR of 19.73% will ensure the quadruple leap.


Regional Analysis:


Geographic analysis of the global market includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).


The Americas, with a market valuation of USD 2999.05 million, are currently the market deciders and an expected rise to USD 10573.53 million can ensure their position in the top. Presence of a large number of biotechnology and synthetic biology companies in the region can take the credit for the region’s supremacy. In addition, youth from the region are more aware of the far-fetching impacts of the market which acts as a tailwind for the market.


However, the APAC is not far behind in gaining momentum and can scale a CAGR of 19.91% during the same period. The region has a huge patient pool suffering from chronic diseases which are impacting the regional market in a significant way. Emerging economies such as India and China are also making remarkable efforts in revamping their medical infrastructure which can consequently boost the market.


Competitive Analysis:


Among the various fields, animal-free leather, electric DNA control, non-browning apples, DNA printing and other are segments that can bring in significant change in the biohacking market. The key players are investing heavily in developing strategies that would give them the advantage to stay ahead of the rest. These strategies often include mergers and acquisitions, along with innovations. The ODIN, at present, is leading the market with 25% of the total market share followed by HVMN, Inc., and Synbiota.


Major companies profiled in the report include ODIN, HVMN, Inc., Synbiota, Apple, Thync Global Inc., U.S.A., Moodmetric, Fitbit, Inc., and others.  

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

2.1 Introduction 19

2.2 Scope of Study 19

2.3 Research Objective 20

2.4 Assumptions & Limitations 20

2.4.1 Assumptions 20

2.4.2 Limitations 20

2.5 Market Structure 21

3.1.1 Primary Research Methodology 23

3.1.2 Secondary Research Methodology 24

3.1.3 Market Share Analysis 25

3.1.4 Trade Analysis 25

3.2 Forecast Model 26

4.1 Introduction 27

4.2 Drivers 28

4.2.1 Rising prevalence of chronic disease (45%) 28

4.2.2 Growing awareness about biohacking (25%) 29

4.2.3 Increasing demand for innovative medical devices and sensors (30%) 30

4.3 Restraints 31

4.3.1 Lack of cyber security practices 31

4.4 Opportunities 32

4.4.1 Technological advancement 32

4.5 Mega Trends 32

4.5.1 Exploration of future biohacking products on rise 32

4.6 Macroeconomic indicators 33

5.1 Value Chain Analysis 34

5.1.1 Primary activities 34

5.1.2 Secondary activities 35

5.2 Porters Five Forces Model 36

5.2.1 Bargaining Power of Suppliers 37

5.2.2 Bargaining Power of Buyers 37

5.2.3 Threat of New Entrants 37

5.2.4 Threat of Substitutes 37

5.2.5 Intensity of Rivalry 38

6.1 Introduction 39

6.2 Outside Biohacking 40

6.3 Inside Biohacking 40

7.1 Introduction 41

7.2 Smart Drugs 42

7.3 Sensors 44

7.4 Strains 45

7.5 Others 46

8.1 Introduction 47

8.2 Synthetic Biology 48

8.3 Genetic Engineering 49

8.4 Forensic science 51

8.5 Diagnosis & Treatment 51

8.6 Drug testing 53

8.7 Others 53

9.1 Introduction 54

9.2 Pharmaceutical & Biotechnology Companies 55

9.3 Forensic Laboratories 55

9.4 Others 56

10.1 Introduction 57

10.2 Americas 58

10.2.1 U.S. 63

10.2.2 Canada 65

10.2.3 South America 68

10.3 Europe 72

10.3.1 Germany 76

10.3.2 France 79

10.3.3 U.K 82

10.3.4 Italy 85

10.3.5 Spain 88

10.3.6 Rest of Western Europe 91

10.3.7 Eastern Europe 94

10.4 Asia Pacific 98

10.4.1 Japan 103

10.4.2 China 105

10.4.3 India 108

10.4.4 Australia 111

10.4.5 Republic of Korea 114

10.4.6 Rest of Asia Pacific 117

10.5 Middle East & Africa 121

10.5.1 United Arab Emirates 125

10.5.2 Saudi Arabia 128

10.5.3 Oman 131

10.5.4 Kuwait 134

10.5.5 Qatar 137

10.5.6 Rest of Middle East & Africa 140

11.1 Introduction: Key Players 144

11.2 Company Share Analysis 144

12.1 Fitbit, Inc. 145

12.1.1 Company Overview 145

12.1.2 Financials 145

12.1.3 Products 145

12.1.4 Strategy 145

12.1.5 Key Developments 145

12.2 Apple 146

12.2.1 Company Overview 146

12.2.2 Financials 146

12.2.3 Products 146

12.2.4 Strategy 146

12.2.5 Key Developments 146

12.3 Synbiota 147

12.3.1 Company Overview 147

12.3.2 Financials 147

12.3.3 Products 147

12.3.4 Strategy 147

12.3.5 Key Developments 147

12.4 THE ODIN 148

12.4.1 Company Overview 148

12.4.2 Financials 148

12.4.3 Products 148

12.4.4 Strategy 148

12.4.5 Key Developments 148

12.5 HVMN, Inc. 149

12.5.1 Company Overview 149

12.5.2 Financials 149

12.5.3 Products 149

12.5.4 Strategy 149

12.5.5 Key Developments 149

12.6 Thync Global Inc., U.S.A. 150

12.6.1 Company Overview 150

12.6.2 Financials 150

12.6.3 Products 150

12.6.4 Strategy 150

12.6.5 Key Developments 150

12.7 MoodMetric 151

12.7.1 Company Overview 151

12.7.2 Financials 151

12.7.3 Products 151

12.7.4 Strategy 151

12.7.5 Key Developments 151

13.1 Key Findings 152

13.1.1 CEO’s Viewpoint 152

13.1.2 Unmet Needs 152

13.1.3 Key Companies to Watch 152

13.1.4 Prediction of Biohacking Industry 152

14.1 Discussion Blue Print 154

14.2 References 156

TABLE 1 PRIMARY INTERVIEWS 23

TABLE 2 GLOBAL BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 39

TABLE 3 GLOBAL BIOHACKING MARKET FOR OUTSIDE BIOHACKING BY REGION, 2014 TO 2023 (USD MILLION) 40

TABLE 4 GLOBAL BIOHACKING MARKET FOR INSIDE BIOHAKCING, BY REGION, 2014 TO 2023 (USD MILLION) 40

TABLE 5 GLOBAL BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 41

TABLE 6 GLOBAL SMART DRUGS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 43

TABLE 7 GLOBAL SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 43

TABLE 8 GLOBAL SENSORS MARKET BY REGION, 2014 TO 2023 (USD MILLION) 44

TABLE 9 GLOBAL STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 45

TABLE 10 GLOBAL STRAINS MARKET BY REGION, 2014 TO 2023 (USD MILLION) 45

TABLE 11 GLOBAL BIOHACKING MARKET BY OTHER PRODUCT, 2014 TO 2023 (USD MILLION) 46

TABLE 12 GLOBAL BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 47

TABLE 13 GLOBAL BIOHACKING MARKET FOR SYNTHETIC BIOLOGY, BY REGION, 2014 TO 2023 (USD MILLION) 49

TABLE 14 GLOBAL BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 50

TABLE 15 GLOBAL BIOHACKING MARKET FOR GENETIC ENGINEERING, BY REGION, 2014 TO 2023 (USD MILLION) 50

TABLE 16 GLOBAL BIOHACKING MARKET FOR FORENSIC SCIENCE, BY REGION, 2014 TO 2023 (USD MILLION) 51

TABLE 17 GLOBAL BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 52

TABLE 18 GLOBAL BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY REGION, 2014 TO 2023 (USD MILLION) 52

TABLE 19 GLOBAL BIOHACKING MARKET FOR DRUG TESTING, BY REGION, 2014 TO 2023 (USD MILLION) 53

TABLE 20 GLOBAL BIOHACKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2014 TO 2023 (USD MILLION) 53

TABLE 21 GLOBAL BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 54

TABLE 22 GLOBAL BIOHACKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES BY REGION, 2014 TO 2023 (USD MILLION) 55

TABLE 23 GLOBAL BIOHACKING MARKET FOR FORENSIC LABORATORIES BY REGION, 2014 TO 2023 (USD MILLION) 55

TABLE 24 GLOBAL BIOHACKING MARKET FOR OTHER END USERS BY REGION, 2014 TO 2023 (USD MILLION) 56

TABLE 25 GLOBAL BIOHACKING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 57

TABLE 26 AMERICAS BIOHACKING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 58

TABLE 27 NORTH AMERICA BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 58

TABLE 28 AMERICAS BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 59

TABLE 29 AMERICAS BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 59

TABLE 30 AMERICAS SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 60

TABLE 31 AMERICAS STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 60

TABLE 32 AMERICAS BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 61

TABLE 33 AMERICAS BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 61

TABLE 34 AMERICAS BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 62

TABLE 35 AMERICAS BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 62

TABLE 36 U.S. BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 63

TABLE 37 U.S. BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 63

TABLE 38 U.S. SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 63

TABLE 39 U.S. STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 64

TABLE 40 U.S. BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 64

TABLE 41 U.S. BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 64

TABLE 42 U.S. BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 65

TABLE 43 U.S. BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 65

TABLE 44 CANADA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 65

TABLE 45 CANADA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 66

TABLE 46 CANADA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 66

TABLE 47 CANADA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 66

TABLE 48 CANADA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 67

TABLE 49 CANADA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 67

TABLE 50 CANADA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 68

TABLE 51 CANADA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 68

TABLE 52 SOUTH AMERICA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 68

TABLE 53 SOUTH AMERICA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 69

TABLE 54 SOUTH AMERICA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 69

TABLE 55 SOUTH AMERICA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 69

TABLE 56 SOUTH AMERICA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 70

TABLE 57 SOUTH AMERICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 70

TABLE 58 SOUTH AMERICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 71

TABLE 59 SOUTH AMERICA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 71

TABLE 60 EUROPE BIOHACKING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 72

TABLE 61 WESTERN EUROPE BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 73

TABLE 62 EUROPE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 74

TABLE 63 EUROPE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 74

TABLE 64 EUROPE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 74

TABLE 65 EUROPE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 75

TABLE 66 EUROPE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 75

TABLE 67 EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 75

TABLE 68 EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 76

TABLE 69 EUROPE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 76

TABLE 70 GERMANY BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 76

TABLE 71 GERMANY BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 77

TABLE 72 GERMANY SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 77

TABLE 73 GERMANY STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 77

TABLE 74 GERMANY BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 78

TABLE 75 GERMANY BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 78

TABLE 76 GERMANY BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 79

TABLE 77 GERMANY BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 79

TABLE 78 FRANCE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 79

TABLE 79 FRANCE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 80

TABLE 80 FRANCE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 80

TABLE 81 FRANCE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 80

TABLE 82 FRANCE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 81

TABLE 83 FRANCE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 81

TABLE 84 FRANCE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 82

TABLE 85 FRANCE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 82

TABLE 86 U.K BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 82

TABLE 87 U.K BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 83

TABLE 88 U.K SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 83

TABLE 89 U.K STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 83

TABLE 90 U.K BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 84

TABLE 91 U.K BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 84

TABLE 92 U.K BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 84

TABLE 93 U.K BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 85

TABLE 94 ITALY BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 85

TABLE 95 ITALY BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 85

TABLE 96 ITALY SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 86

TABLE 97 ITALY STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 86

TABLE 98 ITALY BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 87

TABLE 99 ITALY BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 87

TABLE 100 ITALY BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 88

TABLE 101 ITALY BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 88

TABLE 102 SPAIN BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 88

TABLE 103 SPAIN BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 89

TABLE 104 SPAIN SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 89

TABLE 105 SPAIN STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 89

TABLE 106 SPAIN BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 90

TABLE 107 SPAIN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 90

TABLE 108 SPAIN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 91

TABLE 109 SPAIN BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 91

TABLE 110 REST OF WESTERN EUROPE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 91

TABLE 111 REST OF WESTERN EUROPE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 92

TABLE 112 REST OF WESTERN EUROPE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 92

TABLE 113 REST OF WESTERN EUROPE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 92

TABLE 114 REST OF WESTERN EUROPE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 93

TABLE 115 REST OF WESTERN EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 93

TABLE 116 REST OF WESTERN EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 94

TABLE 117 REST OF WESTERN EUROPE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 94

TABLE 118 EASTERN EUROPE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 94

TABLE 119 EASTERN EUROPE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 95

TABLE 120 EASTERN EUROPE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 95

TABLE 121 EASTERN EUROPE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 95

TABLE 122 EASTERN EUROPE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 96

TABLE 123 EASTERN EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 96

TABLE 124 EASTERN EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 97

TABLE 125 EASTERN EUROPE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 97

TABLE 126 ASIA PACIFIC BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 99

TABLE 127 ASIA PACIFIC BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 99

TABLE 128 ASIA PACIFIC BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 100

TABLE 129 ASIA PACIFIC SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 100

TABLE 130 ASIA PACIFIC STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 100

TABLE 131 ASIA PACIFIC BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 101

TABLE 132 ASIA PACIFIC BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 101

TABLE 133 ASIA PACIFIC BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 102

TABLE 134 ASIA PACIFIC BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 102

TABLE 135 JAPAN BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 103

TABLE 136 JAPAN BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 103

TABLE 137 JAPAN SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 103

TABLE 138 JAPAN STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 104

TABLE 139 JAPAN BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 104

TABLE 140 JAPAN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 104

TABLE 141 JAPAN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 105

TABLE 142 JAPAN BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 105

TABLE 143 CHINA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 105

TABLE 144 CHINA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 106

TABLE 145 CHINA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 106

TABLE 146 CHINA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 106

TABLE 147 CHINA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 107

TABLE 148 CHINA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 107

TABLE 149 CHINA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 108

TABLE 150 CHINA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 108

TABLE 151 INDIA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 108

TABLE 152 INDIA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 109

TABLE 153 INDIA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 109

TABLE 154 INDIA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 109

TABLE 155 INDIA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 110

TABLE 156 INDIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 110

TABLE 157 INDIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 111

TABLE 158 INDIA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 111

TABLE 159 AUSTRALIA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 111

TABLE 160 AUSTRALIA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 112

TABLE 161 AUSTRALIA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 112

TABLE 162 AUSTRALIA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 112

TABLE 163 AUSTRALIA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 113

TABLE 164 AUSTRALIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 113

TABLE 165 AUSTRALIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 114

TABLE 166 AUSTRALIA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 114

TABLE 167 REPUBLIC OF KOREA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 114

TABLE 168 REPUBLIC OF KOREA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 115

TABLE 169 REPUBLIC OF KOREA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 115

TABLE 170 REPUBLIC OF KOREA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 115

TABLE 171 REPUBLIC OF KOREA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 116

TABLE 172 REPUBLIC OF KOREA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 116

TABLE 173 REPUBLIC OF KOREA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 117

TABLE 174 REPUBLIC OF KOREA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 117

TABLE 175 REST OF ASIA PACIFIC BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 117

TABLE 176 REST OF ASIA PACIFIC BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 118

TABLE 177 REST OF ASIA PACIFIC SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 118

TABLE 178 REST OF ASIA PACIFIC STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 118

TABLE 179 REST OF ASIA PACIFIC BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 119

TABLE 180 REST OF ASIA PACIFIC BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 119

TABLE 181 REST OF ASIA PACIFIC BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 120

TABLE 182 REST OF ASIA PACIFIC BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 120

TABLE 183 MIDDLE EAST & AFRICA BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 121

TABLE 184 MIDDLE EAST & AFRICA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 122

TABLE 185 MIDDLE EAST & AFRICA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 122

TABLE 186 MIDDLE EAST & AFRICA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 123

TABLE 187 MIDDLE EAST & AFRICA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 123

TABLE 188 MIDDLE EAST & AFRICA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 124

TABLE 189 MIDDLE EAST & AFRICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 124

TABLE 190 MIDDLE EAST & AFRICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 125

TABLE 191 MIDDLE EAST & AFRICA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 125

TABLE 192 UNITED ARAB EMIRATES BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 125

TABLE 193 UNITED ARAB EMIRATES BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 126

TABLE 194 UNITED ARAB EMIRATES SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 126

TABLE 195 UNITED ARAB EMIRATES STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 126

TABLE 196 UNITED ARAB EMIRATES BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 127

TABLE 197 UNITED ARAB EMIRATES BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 127

TABLE 198 UNITED ARAB EMIRATES BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 128

TABLE 199 UNITED ARAB EMIRATES BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 128

TABLE 200 SAUDI ARABIA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 128

TABLE 201 SAUDI ARABIA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 129

TABLE 202 SAUDI ARABIA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 129

TABLE 203 SAUDI ARABIA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 129

TABLE 204 SAUDI ARABIA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 130

TABLE 205 SAUDI ARABIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 130

TABLE 206 SAUDI ARABIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 131

TABLE 207 SAUDI ARABIA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 131

TABLE 208 OMAN BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 131

TABLE 209 OMAN BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 132

TABLE 210 OMAN SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 132

TABLE 211 OMAN STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 132

TABLE 212 OMAN BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 133

TABLE 213 OMAN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 133

TABLE 214 OMAN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 134

TABLE 215 OMAN BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 134

TABLE 216 KUWAIT BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 134

TABLE 217 KUWAIT BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 135

TABLE 218 KUWAIT SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 135

TABLE 219 KUWAIT STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 135

TABLE 220 KUWAIT BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 136

TABLE 221 KUWAIT BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 136

TABLE 222 KUWAIT BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 137

TABLE 223 KUWAIT BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 137

TABLE 224 QATAR BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 137

TABLE 225 QATAR BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 138

TABLE 226 QATAR SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 138

TABLE 227 QATAR STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 138

TABLE 228 QATAR BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 139

TABLE 229 QATAR BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 139

TABLE 230 QATAR BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 140

TABLE 231 QATAR BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 140

TABLE 232 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 140

TABLE 233 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 141

TABLE 234 REST OF MIDDLE EAST & AFRICA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 141

TABLE 235 REST OF MIDDLE EAST & AFRICA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 141

TABLE 236 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 142

TABLE 237 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 142

TABLE 238 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 143

TABLE 239 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 143



FIGURE 1 GLOBAL BIOHACKING MARKET, BY TYPE, 2016 (%) 15

FIGURE 2 GLOBAL BIOHACKING MARKET, BY PRODUCT, 2016 (%) 16

FIGURE 3 GLOBAL BIOHACKING MARKET, BY APPLICATION, 2016 (%) 16

FIGURE 4 GLOBAL BIOHACKING MARKET, BY END USER, 2016 (%) 17

FIGURE 5 GLOBAL BIOHACKING MARKET, BY REGION, 2016 (%) 18

FIGURE 6 GLOBAL BIOHACKING MARKET: MARKET STRUCTURE 21

FIGURE 7 RESEARCH METHODOLOGY 22

FIGURE 8 GLOBAL BIOHACKING MARKET: FORECAST MODEL 26

FIGURE 9 DROT ANALYSIS OF GLOBAL BIOHACKING MARKET 27

FIGURE 10 GLOBAL BIOHACKING MARKET: VALUE CHAIN 35

FIGURE 11 PORTERS FIVE FORCE MODEL: GLOBAL BIOHACKING MARKET 36

FIGURE 12 GLOBAL BIOHACKING MARKET, BY TYPE, 2016 & 2023 (USD MILLION) 39

FIGURE 13 GLOBAL BIOHACKING MARKET, BY PRODUCT, 2016 & 2023 (USD MILLION) 42

FIGURE 14 GLOBAL BIOHACKING MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION) 48

FIGURE 15 GLOBAL BIOHACKING MARKET, BY END USER, 2016 & 2023 (USD MILLION) 54

FIGURE 16 GLOBAL BIOHACKING MARKET, BY END USER, 2016 & 2023 (USD MILLION) 57

FIGURE 17 AMERICAS BIOHACKING MARKET, BY REGION, 2016 (%) 59

FIGURE 18 EUROPE BIOHACKING MARKET, BY REGION, 2016 (%) 73

FIGURE 19 ASIA PACIFIC BIOHACKING MARKET, BY COUNTRY, 2016 (%) 99

FIGURE 20 MIDDLE EAST & AFRICA BIOHACKIING MARKET, BY COUNTRY, 2016 (%) 122

FIGURE 21 COMPANY SHARE ANALYSIS: 2016 (%) 144

Global Biohacking Market: Competitive Landscape


The global biohacking market is currently dominated by Fitbit, Inc., Apple, Synbiota, THE ODIN, HVMN, Inc., Thync Global Inc., U.S.A., and MoodMetric. Prominent market players are engaged in several strategies such as product launches, partnerships, and acquisitions to enhance their presence in the biohacking market. For instance, Apple Watch is one the most popular products in continuously health monitoring and tracking devices. “watchOS 4” launched by Apple featured G5 Continuous Glucose Monitor (CGM) which become popular among the iPhone users across the globe.


The global biohacking market is led by THE ODIN with 25% of the market share owing to well-developed market and wide range of products offered by the company, which is expected to witness a rise during the assessment period. Further, HVMN, Inc with 16.20%, Synbiota with 12.10%, Fibit with 9%, and Apple with 5.20% accounting for 2nd, 3rd, 4th, and 5th position in global market. Furthermore, rest 32.50% of the market is accounted by other manufacturers for the global biohacking market.


Furthermore, the key players such as Apple are focusing on emerging economies such as Asia Pacific. Apple is a leading market player in medical technology across the globe. The biohacking market in Asia Pacific is driven by the use of herbs and various botanical plants proving to be a successful practice, especially in China. Eushion Industrial Co., Ltd. and Wuxi Fofia Technology Co., Ltd are two companies that are working under biohacking in China.